Diabetes Care Devices Market By Product Type (Blood Glucose Monitoring Devices [Continuous Glucose Monitoring Systems and Self-Monitoring Blood Glucose Systems] and Treatment Devices [Insulin Pens, Insulin Pumps, Insulin Jet Injectors, Insulin Syringes, and Others]), By Technology (Wearable Devices and Non-Wearable Devices), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Stores), and By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Home Care) Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Product Type

• Blood Glucose Monitoring Devices        

• Continuous Glucose Monitoring Systems
• Self-Monitoring Blood Glucose Systems

• Treatment Devices

• Insulin Pens
• Insulin Pumps
• Insulin Jet Injectors
• Insulin Syringes
• Others

By Technology

• Wearable Devices
• Non-Wearable Devices

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Stores

By End-User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Home Care

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Medtronic plc
• Abbott Laboratories
• Roche Diabetes Care
• Dexcom, Inc.
• Ascensia Diabetes Care Holdings AG
• Insulet Corporation
• Novo Nordisk A/S
• Sanofi
• Tandem Diabetes Care, Inc.
• Ypsomed AG
• Becton, Dickinson and Company
• Senseonics Holdings, Inc.
• Eli Lilly and Company
• LifeScan, Inc.
• GlucoMe